<DOC>
	<DOCNO>NCT00375583</DOCNO>
	<brief_summary>This study , conduct Chennai , India , determine whether new treatment regimen albendazole diethylcarbamazine lymphatic filariasis eliminate disease quickly standard regimen . Lymphatic filariasis cause infection small filarial worm , particulalry Wuchereria bancroti , spread mosquito . The infection lead swell arm , leg , breast scrotum progress permanent swell leg arm call elephantiasis . The study see high frequent dose albendazole well clear filarial worm blood current treatment . Healthy people 18 55 year age good health infect Wuchereria bancrofti may eligible 28-month study . Candidates must willing spend 4 day Government General Hospital Chennai , India , begin study . They screen medical history , brief physical examination , ultrasound ( picture generate sound wave ) groin chest , blood test check infection Wuchereria bancrofti measure white blood cell count . Participants undergo follow procedure : -4-day hospitalization Random assignment receive either standard treatment ( 400 mg albendazole 300 mg DEC give year 2 year ) experimental regimen ( 800 mg albendazole 300 mg DEC give twice year 2 year ) Urine pregnancy test woman childbearing age Receive first treatment dose Monitoring symptom -6-month outpatient visit Short history , physical examination blood test Second treatment dose subject receive 800 mg albendazole Urine pregnancy test woman childbearing age -1-year outpatient visit Short history , physical examination blood test Second third treatment dose , depend treatment group Repeat ultrasound subject whose first ultrasound detect adult worm Urine pregnancy test woman childbearing age -18-month outpatient visit Short history , physical examination blood test Fourth treatment dose subject receive 800 mg albendazole Urine pregnancy test woman childbearing age -24-month outpatient visit Short history , physical examination blood test Final dose albendazole DEC standard dose Repeat ultrasound subject whose first ultrasound detect adult worm Urine pregnancy test woman childbearing age</brief_summary>
	<brief_title>Effect Albendazole Dose Clearance Filarial Worms</brief_title>
	<detailed_description>Albendazole diethylcarbamazine ( DEC ) currently use combination annual mass treatment lymphatic filariasis part world except Africa . Although drug donate , cost program high proven major impediment success program many country limit financial resource . Data albendazole treatment filarial infection one study compare single multi-dose DEC/albendazole lymphatic filariasis suggest increase dose and/or frequency albendazole dose may effective clearing microfilariae . In study , 50 volunteer microfilaremic Wuchereria bancrofti infection randomize receive standard annual therapy ( albendazole 400 mg + DEC 300 mg ) semiannual therapy increase albendazole dose ( albendazole 800 mg + DEC 300 mg ) . Microfilarial level , well measure adult worm burden ( circulate antigen , ultrasound identification adult worm nest ) follow every six month two year determine whether high dose , frequent regimen effective .</detailed_description>
	<mesh_term>Filariasis</mesh_term>
	<mesh_term>Elephantiasis</mesh_term>
	<mesh_term>Elephantiasis , Filarial</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<criteria>INCLUSION CRITERIA ( SCREENING ) : Age 18 year 55 year inclusive . Both gender . Not pregnant breastfeed history . If select , subject must willing spend 3 day Clinical Trials Unit Government General Hospital , Chennai India . If select , subject must willing undergo nighttime blood draw every 6 month 2 year . If select , agree blood store future study . Ability understand sign inform consent . EXCLUSION CRITERIA ( SCREENING ) : Nonvolunteers . Age le 18 year great 55 year . Pregnant breastfeed history . INCLUSION ( TREATMENT ) : Age 18 year 55 year . Men nonpregnant nonbreastfeeding woman . Microfilarial level great 50 mf/ml . Willingness spend 3 day Clinical Trials Unit Government General Hospital , Chennai India . Willingness undergo nighttime blood draw every 6 month 2 year . Ability understand sign inform consent . Hb level inclusion great 9 g/dL . Normal Cr , ALT . Willingness blood store future study . EXCLUSION ( TREATMENT ) : Nonvolunteers . Age le 18 year great 55 year . Pregnancy breastfeed . Hgb le equal 9 g/dL . Cr great 1.2/100 ml . ALT great 30 U . Alcohol consumption 2 beer alcoholcontaining drink/day within week drug administration . Temperature great 37.5 degree C. Serious medical illness . History benzimidazole allergy . History DEC allergy . Use albendazole DEC within past 6 month . Unwillingness comply require study visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 28, 2011</verification_date>
	<keyword>Lymphatic Filariasis</keyword>
	<keyword>Diethylcarbamazine</keyword>
	<keyword>Microfilariae</keyword>
	<keyword>Helminths</keyword>
	<keyword>Nematode</keyword>
</DOC>